Arialys Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$14M
- Investors
-
6
Arialys Therapeutics General Information
Description
Operator of a clinical-stage biotechnology company intended to pioneer new precision medicines for autoimmune neuropsychiatric diseases. The company specializes in neuroscience and characterizes the nature and prevalence of pathogenic auto-antibody activity in the central nervous system and converged network services, enabling clients to access advanced breakthrough therapies for a variety of central nervous system disorders and to treat neuropsychiatric disorders driven by autoimmune diseases
Contact Information
Website
www.arialysrx.comCorporate Office
- 11099 North Torrey Pines Road
- Suite 290
- La Jolla, CA 92037
- United States
Corporate Office
- 11099 North Torrey Pines Road
- Suite 290
- La Jolla, CA 92037
- United States
Arialys Therapeutics Timeline
Arialys Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 30-Jun-2025 | $14M | Completed | Clinical Trials - Phase 1 | ||
| 1. Seed Round | 12-Sep-2023 | Completed | Clinical Trials - General |
Arialys Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Arialys Therapeutics Comparisons
Industry
Financing
Details
Arialys Therapeutics Competitors (80)
One of Arialys Therapeutics’s 80 competitors is Johnson&Johnson Innovative Medicine, a Venture Capital-Backed company based in Raritan, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Johnson&Johnson Innovative Medicine | Venture Capital-Backed | Raritan, NJ | ||||
| Dicerna Pharmaceuticals | Formerly VC-backed | Lexington, MA | ||||
| ORIC Pharmaceuticals | Formerly VC-backed | South San Francisco, CA | ||||
| Astellas Pharma | Corporation | Tokyo, Japan | ||||
| Bridge Medicines | Venture Capital-Backed | New York, NY |
Arialys Therapeutics Patents
Arialys Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026232008-A1 | Cd98 binding polypeptides and uses thereof | Pending | 02-May-2025 | ||
| WO-2026073156-A1 | Detection of autoantibodies against nr1 | Pending | 30-Sep-2024 | ||
| WO-2026020040-A1 | Methods of treating anti-nmdar antibody related disorders | Pending | 19-Jul-2024 | ||
| AU-2024242885-A1 | Detection of autoantibodies against nr1 | Pending | 30-Mar-2023 | ||
| EP-4689655-A1 | Detection of autoantibodies against nr1 | Pending | 30-Mar-2023 | G01N33/564 |
Arialys Therapeutics Signals
Arialys Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Real Estate Equities | Real Estate | Minority | ||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Avalon Bioventures | Venture Capital | Minority | ||
| Catalys Pacific | Venture Capital | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority |
Arialys Therapeutics FAQs
-
When was Arialys Therapeutics founded?
Arialys Therapeutics was founded in 2021.
-
Where is Arialys Therapeutics headquartered?
Arialys Therapeutics is headquartered in La Jolla, CA.
-
What is the size of Arialys Therapeutics?
Arialys Therapeutics has 10 total employees.
-
What industry is Arialys Therapeutics in?
Arialys Therapeutics’s primary industry is Drug Discovery.
-
Is Arialys Therapeutics a private or public company?
Arialys Therapeutics is a Private company.
-
What is the current valuation of Arialys Therapeutics?
The current valuation of Arialys Therapeutics is .
-
What is Arialys Therapeutics’s current revenue?
The current revenue for Arialys Therapeutics is .
-
How much funding has Arialys Therapeutics raised over time?
Arialys Therapeutics has raised $72M.
-
Who are Arialys Therapeutics’s investors?
Alexandria Real Estate Equities, Alexandria Venture Investments, Avalon Bioventures, Catalys Pacific, and Johnson & Johnson JJDC are 5 of 6 investors who have invested in Arialys Therapeutics.
-
Who are Arialys Therapeutics’s competitors?
Johnson&Johnson Innovative Medicine, Dicerna Pharmaceuticals, ORIC Pharmaceuticals, Astellas Pharma, and Bridge Medicines are some of the 80 competitors of Arialys Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process